{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:05:22Z","timestamp":1784372722647,"version":"3.55.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:00:00Z","timestamp":1529539200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01416","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T04:21:23Z","timestamp":1529554883000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Nonallergic Asthma and Its Severity: Biomarkers for Its Discrimination in Peripheral Samples"],"prefix":"10.3389","volume":"9","author":[{"given":"Selene","family":"Baos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Calzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Cremades-Jimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Quiralte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Florido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lahoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"C\u00e1rdaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"key":"B1","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention2017"},{"key":"B2","doi-asserted-by":"publisher","first-page":"32883","DOI":"10.1074\/jbc.R110.197046","article-title":"Allergic asthma: influence of genetic and environmental factor","volume":"286","author":"Mukherjee","year":"2011","journal-title":"J Biol Chem"},{"key":"B3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2049-6958-9-23","article-title":"Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review","volume":"9","author":"D\u2019Amato","year":"2014","journal-title":"Multidiscip Respir Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/bcp.12036","article-title":"Stratified approaches to the treatment of asthma","volume":"76","author":"Holgate","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jaip.2014.09.006","article-title":"Asthma phenotypes: nonallergic (intrinsic) asthma","volume":"2","author":"Peters","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1067\/mai.2003.1595","article-title":"Allergic and nonallergic forms of atopic diseases","volume":"112","author":"Novak","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e100645","DOI":"10.1371\/journal.pone.0100645","article-title":"Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma","volume":"9","author":"Green","year":"2014","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/thx.2009.120741","article-title":"Prosurvival activity for airway neutrophils in severe asthma","volume":"65","author":"Uddin","year":"2010","journal-title":"Thorax"},{"key":"B10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jaci.2013.07.036","article-title":"Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma","volume":"133","author":"Peters","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/thorax.57.10.875","article-title":"Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids","volume":"57","author":"Green","year":"2002","journal-title":"Thorax"},{"key":"B12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1465-9921-7-135","article-title":"IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?","volume":"7","author":"Bullens","year":"2006","journal-title":"Respir Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2222.2012.04075.x","article-title":"Impaired macrophage phagocytosis in non-eosinophilic asthma","volume":"43","author":"Simpson","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"B14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaci.2014.07.046","article-title":"Identification of novel immune phenotypes for allergic and nonallergic childhood asthma","volume":"135","author":"Raedler","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/all.12616","article-title":"EAACI IG biologicals task force paper on the use of biologic agents in allergic disorders","volume":"70","author":"Boyman","year":"2015","journal-title":"Allergy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1146\/annurev-pharmtox-010814-124407","article-title":"Novel targeted therapies for eosinophil-associated diseases and allergy","volume":"55","author":"Radonjic-Hoesli","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/CPAA.S119295","article-title":"CRTH2 antagonists in asthma: current perspectives","volume":"15","author":"Singh","year":"2017","journal-title":"Clin Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.2147\/DDDT.S147389","article-title":"Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting \u03b22-agonists in patients with atopic asthma","volume":"4","author":"Bateman","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00670-2017","article-title":"Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids","volume":"50","author":"Bateman","year":"2017","journal-title":"Eur Respir J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.jaci.2016.03.010","article-title":"Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis\u2014PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"137","author":"Muraro","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.dib.2016.12.035","article-title":"Data set on a study of gene expression in peripheral samples to identify biomarkers of severity of allergic and nonallergic asthma","volume":"10","author":"Baos","year":"2016","journal-title":"Data Brief"},{"key":"B22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.molimm.2016.12.012","article-title":"Biomarkers associated with disease severity in allergic and nonallergic asthma","volume":"82","author":"Baos","year":"2017","journal-title":"Mol Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0300-2896(09)73459-3","article-title":"GEMA (Gu\u00eda espa\u00f1ola del manejo del asma)","volume":"45","year":"2009","journal-title":"Arch Bronconeumol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jaci.2012.06.025","article-title":"Periostin a systemic biomarker of eosinophilic airway inflammation in asthmatic patients","volume":"130","author":"Jia","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/MCP.0000000000000005","article-title":"Periostin, a novel biomarker of Th2-driven asthma","volume":"20","author":"Parulekar","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ymeth.2004.08.020","article-title":"Biomarker discovery in biological fluids","volume":"35","author":"Gao","year":"2005","journal-title":"Methods"},{"key":"B27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2500\/aap.2016.37.3932","article-title":"Protective effects of elafin against adult asthma","volume":"37","author":"Tsai","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.biocel.2012.05.007","article-title":"The WAP protein Trappin-2\/Elafin: a handyman in the regulation of inflammatory and immune responses","volume":"44","author":"Verrier","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury","volume":"73","author":"Lee","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.cellsig.2013.03.016","article-title":"Diverse pathological implications of YKL-40: answers may lie in \u2018outside-in\u2019 signaling","volume":"25","author":"Prakash","year":"2013","journal-title":"Cell Signal"},{"key":"B31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jaci.2015.11.020","article-title":"Multidimensional endotyping in patients with severe asthma reveals inflammatory heterogeneity in matrix metalloproteinases and chitinase 3-like protein 1","volume":"138","author":"Hinks","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5858\/arpa.2013-0182-RA","article-title":"Interleukin 8 and acute lung injury","volume":"138","author":"Allen","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12016-015-8514-7","article-title":"Regulator versus effector paradigm: interleukin-10 as indicator of the switching response","volume":"50","author":"Mingomataj","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/gene.2014.45","article-title":"Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-\u03b2","volume":"15","author":"Palomares","year":"2014","journal-title":"Genes Immun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0021-9150(01)00624-4","article-title":"Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors","volume":"161","author":"Tomokiyo","year":"2002","journal-title":"Atherosclerosis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1615\/CritRevImmunol.2014010267","article-title":"Scavenger receptor-A (CD204): a two-edged sword in health and disease","volume":"34","author":"Kelley","year":"2014","journal-title":"Crit Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1165\/rcmb.2009-0324RT","article-title":"Mast cell peptidase: chameleons of innate immunity and host defense","volume":"42","author":"Trivedi","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jaci.2013.12.1091","article-title":"Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes","volume":"133","author":"Baines","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B40","first-page":"5230","article-title":"Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"15858","DOI":"10.1073\/pnas.0707413104","article-title":"Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids","volume":"104","author":"Woodruff","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1189\/jlb.0304182","article-title":"Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes","volume":"76","author":"Swartz","year":"2004","journal-title":"J Leukoc Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1146\/annurev.immunol.22.012703.104716","article-title":"Asthma: mechanisms of disease persistence and progression","volume":"22","author":"Cohn","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e0126035","DOI":"10.1371\/journal.pone.0126035","article-title":"Analysis of a panel of 48 cytokines in BAL fluids specifically identifies IL-8 levels as the only cytokine that distinguishes controlled asthma from uncontrolled asthma, and correlates inversely with FEV1","volume":"10","author":"Hosoki","year":"2015","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/1753465816632638","article-title":"Novel approaches to the management of noneosinophilic asthma","volume":"10","author":"Thomson","year":"2016","journal-title":"Ther Adv Respir Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pupt.2017.05.012","article-title":"Effects of the CXCR2 antagonist AZD5069 on lung neutrophil recruitment in asthma","volume":"45","author":"Watz","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S2213-2600(16)30227-2","article-title":"Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial","volume":"4","author":"O\u2019Byrne","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1056\/NEJMoa073600","article-title":"A chitinase-like protein in the lung and circulation of patients with severe asthma","volume":"357","author":"Chupp","year":"2007","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"25117","DOI":"10.3402\/ecrj.v2.25117","article-title":"YKL-40 and genetic status of CHI3L1 in a large group of asthmatics","volume":"2","author":"Hansen","year":"2015","journal-title":"Eur Clin Resp J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01416\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T04:21:44Z","timestamp":1529554904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01416\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2018.01416"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01416","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,21]]},"article-number":"1416"}}